4 studies found for:    22658127 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MK-3475;   Drug: Docetaxel
2 Recruiting Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
Conditions: Head and Neck Squamous Cell Carcinoma;   Metastatic Renal Cell Cancer;   Recurrent Head and Neck Carcinoma;   Recurrent Lung Carcinoma;   Recurrent Renal Cell Carcinoma;   Recurrent Skin Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Lung Cancer;   Stage IV Skin Melanoma
Interventions: Radiation: Radiation Therapy (RT);   Drug: MK-3475
3 Recruiting Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Condition: Neoplasms
Intervention: Genetic: Blood and tumor samples
4 Active, not recruiting A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC);   Renal Cell Carcinoma (RCC);   Metastatic Melanoma (MEL);   Non-small Cell Lung Cancer (NSCLC)
Intervention: Biological: BMS-936558 (MDX-1106)

Indicates status has not been verified in more than two years